Bendamustine in Acute Leukemia and MDS

NCT00790855 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

27

Enrollment

OTHER

Sponsor class

Stopped Lack of Response

Conditions

Acute Myeloid Leukemia
Myelodysplastic Syndrome
Acute Lymphoblastic Leukemia
Chronic Myeloid Leukemia

Interventions

DRUG: Bendamustine

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]